Related references
Note: Only part of the references are listed.Prescribing pattern and resource utilization of monoamine oxidase-B inhibitors in Parkinson treatment: comparison between rasagiline and selegiline
Luca Degli Esposti et al.
NEUROLOGICAL SCIENCES (2016)
Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review
Joana Bicker et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach
Chandrakantsing V. Pardeshi et al.
DRUG DELIVERY (2013)
Blood-brain barrier structure and function and the challenges for CNS drug delivery
N. Joan Abbott
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
C. Warren Olanow et al.
MOVEMENT DISORDERS (2013)
ROTENONE-INDUCED PARKINSONISM ELICITS BEHAVIORAL IMPAIRMENTS AND DIFFERENTIAL EXPRESSION OF PARKIN, HEAT SHOCK PROTEINS AND CASPASES IN THE RAT
M. Sonia Angeline et al.
NEUROSCIENCE (2012)
Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels
Tofeeq Ur-Rehman et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery
Tais Gratieri et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Parkinson's Disease Symptoms: The Patient's Perspective
Marios Politis et al.
MOVEMENT DISORDERS (2010)
Mucoadhesive Polymeric Hydrogels for Nasal Delivery of Acyclovir
Ibrahim A. Alsarra et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2009)
Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic Stroke
Leah R. Hanson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Behavioral alterations in rotenone model of Parkinson's disease: Attenuation by co-treatment of centrophenoxine
Bimla Nehru et al.
BRAIN RESEARCH (2008)
Permeation enhancer effect of chitosan and chitosan derivatives: Comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells
A. M. M. Sadeghi et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
William J. Burke et al.
ACTA NEUROPATHOLOGICA (2008)
Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties
Noha M. Zaki et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Selegiline transdermal system - In the treatment of major depressive disorder
James E. Frampton et al.
DRUGS (2007)
Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness
MBH Youdim et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
A review of poloxamer 407 pharmaceutical and pharmacological characteristics
Gilles Dumortier et al.
PHARMACEUTICAL RESEARCH (2006)
Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease
Matthias R. Lemke et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
The therapeutic potential of monoamine oxidase inhibitors
MBH Youdim et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives
MI Ugwoke et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Nasal drug administration: Potential for targeted central nervous system delivery
CL Graff et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures
CM Testa et al.
MOLECULAR BRAIN RESEARCH (2005)
Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration
VN Uversky
CELL AND TISSUE RESEARCH (2004)
Mechanism for generation of hydrogen peroxide and change of mitochondrial membrane potential during rotenone-induced apoptosis
S Tada-Oikawa et al.
LIFE SCIENCES (2003)
Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats
M Alam et al.
BEHAVIOURAL BRAIN RESEARCH (2002)
Prion channel proteins and their role in vacuolation and neurodegenerative diseases
JI Kourie
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2002)
Efficacy of elevated body swing test in the early model of Parkinson's disease in rat
M Roghani et al.
PHYSIOLOGY & BEHAVIOR (2002)
Treatment interventions for Parkinson's disease: an evidence based assessment
O Rascol et al.
LANCET (2002)
Dopamine D2 receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects
MLG Wadenberg et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs
HD Kao et al.
PHARMACEUTICAL RESEARCH (2000)
Share Paper
